Ingredient or product comparison
GHK-Cu for Age Spots Research: Comparison Table
Before choosing a peptide compound for hyperpigmentation research, understanding how GHK-Cu compares to alternative treatments clarifies its specific advantages and limitations. GHK-Cu (topical 1–3%) Tyrosinase inhibition + MMP modulation 8–12 weeks Epidermal
This source-based comparison does not add ratings or recommend a winner.
- Before choosing a peptide compound for hyperpigmentation research, understanding how GHK-Cu compares to alternative treatments clarifies its specific advantages and limitations.
- GHK-Cu (topical 1–3%)
- Tyrosinase inhibition + MMP modulation
- 8–12 weeks
- Epidermal + upper dermal
- Optimal for Fitzpatrick II–IV; limited data for V–VI
- Best for research into melanocyte regulation without photosensitivity risk; requires formulation stability controls
- Hydroquinone 2–4%
- Competitive tyrosinase inhibition + melanocyte cytotoxicity
- 4–8 weeks
- Epidermal only
- All skin types; risk of ochronosis in darker skin with prolonged use
- Faster onset than GHK-Cu but higher adverse event profile; not suitable for long-term continuous use
- Kojic Acid 1–4%
- Copper chelation (tyrosinase cofactor removal)
- 6–10 weeks
- Epidermal
- All skin types; irritation common above 2%
- Mechanism overlaps with GHK-Cu but lacks dermal remodeling component; unstable in water-based formulations
- Niacinamide 4–5%
- Melanin transfer inhibition (melanosome blockade)
- All skin types; well-tolerated
- Does not reduce melanin synthesis. Only transfer; complementary to GHK-Cu rather than competitive
- Laser (Q-switched Nd:YAG)
- Selective photothermolysis of melanin granules
- Immediate (crust formation 7–14 days)
- Epidermal + dermal
- Risk of post-inflammatory hyperpigmentation in Fitzpatrick IV+
- Fastest clearance but highest cost and downtime; does not prevent recurrence without melanocyte regulation